BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05675579-completion@plaintrial.com
DTSTAMP:20260926T152829Z
DTSTART;VALUE=DATE:20261231
SUMMARY:A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembroliz
 umab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative 
 Breast Cancer (TNBC) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05675579
URL:https://plaintrial.com/trial/NCT05675579
END:VEVENT
END:VCALENDAR